Cited by 115Cancer, Hypoxia, and MetabolismAntimicrobial Resistance in StaphylococcusBacterial biofilms and quorum sensing

A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection

Open access
Okumura, Cheryl Y. M., Hollands, Andrew, Tran, Dan N., Olson, Joshua, Dahesh, Samira, von Köckritz-Blickwede, Maren, Thienphrapa, Wdee, Corle, Courtney +5 more·2012·Journal of Molecular Medicine

Abstract

Hypoxia inducible factor-1 (HIF-1) is a transcription factor that is a major regulator of energy homeostasis and cellular adaptation to low oxygen stress. HIF-1 is also activated in response to bacterial pathogens and supports the innate immune response of both phagocytes and keratinocytes. In this work, we show that a new pharmacological compound AKB-4924 increases HIF-1 levels and enhances the antibacterial activity of phagocytes and keratinocytes against both methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus in vitro. AKB-4924 is also effective in stimulating the killing capacity of keratinocytes against the important opportunistic skin pathogens Pseudomonas aeruginosa and Acinetobacter baumanii. The effect of AKB-4924 is mediated through the activity of host cells, as the compound exerts no direct antimicrobial activity. Administered locally as a single agent, AKB-4924 limits S. aureus proliferation and lesion formation in a mouse skin abscess model. This approach to pharmacologically boost the innate immune response via HIF-1 stabilization may serve as a useful adjunctive treatment for antibiotic-resistant bacterial infections.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00109-012-0882-3

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 48 · Cited by 115

Authors
Okumura, C. Y. M., Hollands, A., Tran, D. N., Olson, J., Dahesh, S., von Köckritz-Blickwede, M., Thienphrapa, W., Corle, C., Jeung, S. N., Kotsakis, A., Shalwitz, R. A., Johnson, R. S., & Nizet, V.
Affiliations
  • University of California San Diego (US)
  • Aerpio Pharmaceuticals (United States) (US)
Corresponding author
Nizet, Victor
Venue
Journal of Molecular Medicine
Published
2012-02-28
Volume
90
Issue
9
Pages
1079-1089
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W2078721739
Cited by
115
References
48
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 8 · 2019: 5 · 2018: 9 · 2017: 8 · 2016: 20 · 2015: 9 · 2014: 12 · 2013: 12 · 2012: 3
FWCI
3.92
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Wellcome Trust (092738/Z/10/Z)
  • National Institutes of Health
  • National Institute of General Medical Sciences (GM06852)
  • National Institute of Allergy and Infectious Diseases (R01AI093451, R56AI090863, AI090863)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Keywords
HIF-1, skin innate immunity, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, keratinocytes, phagocytes, antibacterial activity, skin abscess, antibiotic-resistant bacterial infections, adjunctive therapy
MeSH terms
Animals, Anti-Bacterial Agents, Cell Line, Female, Humans, Immunity, Innate, Phagocytes, Piperazines, Pyridones, Skin, Staphylococcal Infections, Staphylococcus aureus, Keratinocytes, Skin Diseases, Bacterial, Mice, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review